Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05398185 · ClinicalTrials.gov registry record · NA
WiseApp for Spanish Speakers Living With HIV
A NA study of HIV Infections and Sexually Transmitted Diseases, Viral, sponsored by Columbia University.
- Recruiting
- Registry status
- NA
- Development phase
- 248
- Enrollment target
- 2
- Study locations
NCT05398185: Recruiting NA study of HIV Infections and Sexually Transmitted Diseases, Viral, sponsored by Columbia University.
NCT05398185 is a NA study of HIV Infections and Sexually Transmitted Diseases, Viral that is actively recruiting participants, run by Columbia University. The registered enrollment target is 248 participants, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (44% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05398185, a NA study of HIV Infections and Sexually Transmitted Diseases, Viral, is actively recruiting participants, sponsored by Columbia University.
- RECRUITING
- Registry status
- NA
- Development phase
- 248 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study aims to conduct a 12-month randomized controlled trial to adapt the mobile app, WiseApp, and a smart pill dispenser for Spanish-speaking people living with HIV (PLWH) in the New York City (NYC) area and La Romana, Dominican Republic (DR). The study will assess the efficacy and sustainability of WiseApp as well as identify barriers with its widespread use among Spanish speakers. With disproportionately high rates of HIV in the New York City area and the Dominican Republic, this project seeks to identify distinct contextual factors related to Spanish speaking people living with HIV and increase the likelihood of engagement with technology and improvements in clinical outcomes.
Primary Outcome
Self-reported ART adherence is a single-item self-report measure on a linear scale of 0-100 with zero indicating lowest adherence and 100 indicating highest adherence.
Conditions Studied
Interventions
- DEVICE CleverCap
Study Locations (2)
New York
- Columbia University Irving Medical Center - New York
Other
- Clinica de Familia La Romana - La Romana
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 248 participants |
| Start Date | 2023-03-01 |
| Est. Completion | 2027-01 |
| Phase | NA |
What NCT05398185 shows while recruiting
NCT05398185 is an interventional study that assigns participants to a tested intervention. The registered 248 participants enrollment target is mid-sized for trials with a published cap, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (44% lower).
The record links to 3 conditions, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which CleverCap is the first listed.
NCT05398185 reports a single indexed study location in New York, Other.
Frequently Asked Questions
What is clinical trial NCT05398185 about?
NCT05398185 is a clinical study titled "WiseApp for Spanish Speakers Living With HIV". This study aims to conduct a 12-month randomized controlled trial to adapt the mobile app, WiseApp, and a smart pill dispenser for Spanish-speaking people living with HIV (PLWH) in the New York City (NYC) area and La Romana, Dominican Republic (DR). The study will assess the efficacy and sustainabil...
What is the current status of trial NCT05398185?
This trial is currently recruiting. It is a NA study. The enrollment target is 248 participants. The study started on 2023-03-01. Estimated completion is 2027-01.
What conditions does trial NCT05398185 study?
This clinical trial studies the following conditions: HIV Infections, Sexually Transmitted Diseases, Viral, Acquired Immune Deficiency Syndrome.
What interventions are being tested in trial NCT05398185?
The interventions under investigation include: CleverCap (DEVICE).
Who is sponsoring clinical trial NCT05398185?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05398185 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05398185's enrollment target sits among peer trials
248 148th of 542 higher than 395 of 542 other HIV Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
-
Substance Checking Outreach and Pre-Exposure Prophylaxis (PrEP) Engagement Study
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
-
Screen Smart: Using Digital Health to Improve HIV Screening and Prevention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04577911 · 248 participants
How is Social Connection Represented in the Brain?
- NCT04777994 · 248 participants · Phase 1
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
- NCT04792489 · 248 participants · Phase 2
DALY II USA/ MB-CART2019.1 for DLBCL
- NCT04830137 · 248 participants · Phase 1
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI